Bill > HB2462

This bill amends the Epinephrine Injector Act to improve emergency response to severe allergic reactions (anaphylaxis). The bill introduces the concept of an "authorized individual," defined as someone who has completed a specific anaphylaxis training program, and expands the definition of an "epinephrine delivery system" to include any FDA-approved device for administering epinephrine to treat life-threatening allergic reactions. The legislation allows health care practitioners to prescribe epinephrine delivery systems to authorized entities or individuals, and permits trained employees or other authorized individuals to provide or administer epinephrine to someone experiencing anaphylaxis, even without a prior prescription or diagnosed allergy. The training program, which must be conducted by a nationally recognized organization, covers recognizing allergic reaction symptoms and proper epinephrine administration, and results in a two-year certification. Importantly, the bill provides good Samaritan protections for authorized individuals who act in good faith when providing or administering epinephrine, shielding them from civil liability except in cases of willful and wanton misconduct. The bill aims to increase preparedness and safety in settings where severe allergic reactions might occur, such as schools, workplaces, restaurants, and public venues.

Health and Social Services, Justice

https://www.ilga.gov/legislation/BillStatus.asp?DocNum=2462&GAID=18&DocTypeID=HB&SessionID=114&GA=104